
IndraLab
Statements
reach
"In vivo studies conducted in mouse models indicate that topical application of silibinin inhibits UVB induced expression levels of ERK1/2 and p38 proteins of MAPK family, and subsequently inhibited the activation of NF-kappaB and p65 through inhibition of degradation of IkappaBalpha and activation of IKKalpha."